Jefferies Downgrades Amyris to Hold, Lowers Price Target to $0.65
Canaccord Genuity Initiates Coverage On Amyris With Buy Rating, Announces Price Target of $1.5
Piper Sandler Adjusts Amyris' Price Target to $1 From $1.50, Keeps Neutral Rating
Piper Sandler Maintains Neutral on Amyris, Lowers Price Target to $1
Amyris Analyst Ratings
Oppenheimer Downgrades Amyris to Perform From Outperform, Removes $22 Price Target
Amyris Analyst Ratings